HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma
BackgroundGlioma, the most prevalent and aggressive primary malignant brain tumor, is associated with poor clinical outcomes. There is an urgent need for novel biomarkers to predict survival and therapeutic response, as existing markers offer limited p…